ASD FMT Clinical Research
- Conditions
- Autism Spectrum DisorderASD, Autism Spectrum DisorderD000067877
- Registration Number
- JPRN-jRCTs031230041
- Lead Sponsor
- Tanaka Yoshimu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
1. Children between the ages of 5 and 12,
regardless of gender, who have recently been
diagnosed with ASD by a board-certified pediatric
neurologist of The Japanese Society of Child
Neurology, a board-certified psychiatrist of
The Japanese Society for Psychiatry and Neurology,
a board-certified member of The Japanese Society
for Child and Adolescent Psychiatry, or a
board-certified member of Japanese Society of
Pediatric Psychiatry and Neurology.
2. Generally good physical health aside from
gastrointestinal problems.
3. Children who are able to give informed assent
to take part in the clinical study.
4. Children who are able to obtain informed
consent from their legally authorized
representatives to take part in the clinical study.
1. Currently on treatment with medicines.
2. Received antibiotics (excluding topical
antibiotics) within the last three months.
3. Received fecal microbiota transplantation
within the last 12 months.
4. Children with a single gene disorder
(Fragile X, Rett Syndrome, Joubert Syndrome,
etc. which may affect the evaluation of ASD).
5. Children with neurosurgical or neurological
diseases.
6. Currently on tube feeding.
7. Severely underweight and malnourished
less than 65% of a standard body weight.
8. Had surgery within the last 12 months or
are scheduled to have surgery within the
next six months.
9. Current participation in other clinical trials.
10. Children who are judged by a principal
investigator to be unsuitable for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method